Believe it or not, medications are recalled on a daily basis for numerous reasons. Medication recalls can range from minor to life-threatening incidents if not immediately and appropriately taken care of.
One of the most recent recalls involves acyclovir 400 mg tablets, used for the treatment of shingles, herpes, and chickenpox.
Why was acyclovir recalled?
Apace Packaging LLC has issued a nationwide voluntary recall of acyclovir, with the knowledge of the FDA, due to a product mix-up. A small number of blister cards containing acyclovir 400 mg tablets may potentially also include torsemide, which is indicated for high blood pressure.
Missing a dose of acyclovir could result in reactivation of the virus being treated, and unintentional ingestion of torsemide could result in increased urination, decreased blood pressure, and other more serious adverse events.
Have there been any adverse events reported?
No. At this time, Apace Packaging LLC has not received any reports of adverse events due to this recall.
Which acyclovir products were recalled?
According to the Apace Packaging press release, the affected product was fully distributed to R&S Northeast, and then further distributed nationwide.
The recall will affect the following:
- Drug(s): Acyclovir 400 mg tablets
- Manufacturer: AvKare Pharmaceuticals. Packaged by: Apace Packaging LLC
- Packaging: Carton and blister cards
- National Drug Code (NDC): 50268-061-15 (carton), 50268-061-11 (blister card)
- Lot(s) & Expiration date(s): Lot: 19900, expiration: 05/2019
What has been done to alert those who may be affected?
Apace Packaging is notifying distributors and customers by email and is arranging for return of all recalled products. Distributors that have any of the product being recalled should contact customer service at AvKARE, Inc. at 931-292-6222 to arrange for the return of the product.
Always inspect your medications, including all parts of the packaging and devices. If you ever notice your medication doesn’t look or smell right, contact the manufacturer or ask your pharmacist for more information. You can also notify the FDA’s MedWatch Reporting Program as they can conduct further necessary investigations.
We've sent a link to download the GoodRx mobile app to your phone.
We were unable to send a link to your phone.